High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma

Cancer

Volumn 89, Issue 7, 2000, Pages 1526-1531

  Oka, Kuniyuki ^a,b,c   Suzuki, Yoshiyuki ^a   Nakano, Takashi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b Mito Saiseikai General Hospital   (Japan)

^c Mito Saiseikai General Hospital   (Japan)

Author keywords

9 grays; Cervical squamous cell carcinoma; Growth fraction; MIB 1 labeling index; Prognosis; Radiotherapy

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CORRELATION FUNCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANIMAL; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CERVIX NEOPLASMS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICE; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0034306865     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20001001)89:7<1526::AID-CNCR16>3.0.CO;2-2     Document Type: Article

References (25)

1. Prediction of cervical carcinoma response to radiotherapy
2. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC Cooperative Trial 22851
3. Biologic basis of radiation therapy
4. MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy
5. Relative changes of MIB1 and PC10 labeling indexes in cell kinetics during radiotherapy for cervical squamous cell carcinoma
6. Transition of Ki-67 index of uterine cervical tumors during radiation therapy
7. Differential values of Ki-67 index and mitotic index of proliferating cell population: An assessment of cell cycle and prognosis in radiation therapy for cervical cancer
8. Transient increases of growth fraction during fractionated radiotherapy for cervical carcinoma: Ki-67 and PC10 immunostaining
9. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma
10. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
11. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
12. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast
13. Biologic basis for altered fractionation schemes
14. High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience
15. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
16. New Ki-67-equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope
17. Changes of Ki67 index of various tumors during radiation therapy
18. Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?
19. MIB1 immunostaining in stage I squamous cervical carcinoma: Relationship with natural killer cell activity
20. Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma, Relation to the results of radiotherapy
21. Tumor-proliferative fraction and growth fraction expression as markers of tumor response to radiotherapy in cancer of the uterine cervix
22. Markers of radioresistance in squamous cell carcinomas of the head and neck: A clinicopathological study
23. Cell kinetics to monitor radioresponsivity in human epidermoid carcinoma